港股异动|中国联通(0762.HK)大涨近5%领涨蓝筹中期多赚16%
格隆汇8月15日丨受业绩影响,中国联通(0762.HK)今日大涨4.82%,居蓝筹股涨幅首位。报7.39港元,暂成交1.93亿港元,最新总市值2252亿港元。A股中国联通相对较弱,股价小幅下跌。中国联通昨日晚间披露半年报,公司2019年上半年实现净利润30.16亿元,同比增长16.8%。营收同比下降2.8%,净利润却增加16%,主要由于网络、运营及支撑成本减少69.44亿元,同比下降25%所致。招商证券点评称,公司业绩符合预期,产业物联网增长强劲,予强烈推荐。值得注意的是,股东方面,与一季报相比相比,陆股通二季度增持中国联通0.26%股份,在十大流通股东中位列第三。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.